{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:44:02Z","timestamp":1790081042769,"version":"4.0.1"},"publisher-location":"Cham","reference-count":131,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030678135","type":"print"},{"value":"9783030678142","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/5584_2020_488","type":"book-chapter","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T07:02:44Z","timestamp":1580886164000},"page":"191-210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Interleukin-36: Structure, Signaling and Function"],"prefix":"10.1007","author":[{"given":"Li","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Todorovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,6]]},"reference":[{"issue":"2","key":"488_CR1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.molcel.2011.07.037","volume":"44","author":"IS Afonina","year":"2011","unstructured":"Afonina IS et al (2011) Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1alpha. Mol Cell 44(2):265\u2013278","journal-title":"Mol Cell"},{"issue":"34","key":"488_CR2","doi-asserted-by":"crossref","first-page":"10786","DOI":"10.1073\/pnas.1422749112","volume":"112","author":"H Agerstam","year":"2015","unstructured":"Agerstam H et al (2015) Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia. Proc Natl Acad Sci U S A 112(34):10786\u201310791","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"488_CR3","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1182\/blood-2015-11-679985","volume":"128","author":"H Agerstam","year":"2016","unstructured":"Agerstam H et al (2016) IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models. Blood 128(23):2683\u20132693","journal-title":"Blood"},{"issue":"13","key":"488_CR4","doi-asserted-by":"crossref","first-page":"E2748","DOI":"10.1073\/pnas.1620954114","volume":"114","author":"JS Ainscough","year":"2017","unstructured":"Ainscough JS et al (2017) Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36gamma. Proc Natl Acad Sci U S A 114(13):E2748\u2013E2757","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"488_CR5","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","volume":"360","author":"I Aksentijevich","year":"2009","unstructured":"Aksentijevich I et al (2009) An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 360(23):2426\u20132437","journal-title":"N Engl J Med"},{"issue":"5","key":"488_CR6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1080\/15321819.2018.1520128","volume":"39","author":"F Alsahebfosoul","year":"2018","unstructured":"Alsahebfosoul F et al (2018) Serum level of interleukin 36 in patients with multiple sclerosis. J Immunoassay Immunochem 39(5):558\u2013564","journal-title":"J Immunoassay Immunochem"},{"issue":"4","key":"488_CR7","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/mi.2016.107","volume":"10","author":"T Aoyagi","year":"2017","unstructured":"Aoyagi T et al (2017a) IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia. Mucosal Immunol 10(4):1043\u20131055","journal-title":"Mucosal Immunol"},{"issue":"11","key":"488_CR8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006737","volume":"13","author":"T Aoyagi","year":"2017","unstructured":"Aoyagi T et al (2017b) Interleukin-36gamma and IL-36 receptor signaling mediate impaired host immunity and lung injury in cytotoxic Pseudomonas aeruginosa pulmonary infection: role of prostaglandin E2. PLoS Pathog 13(11):e1006737","journal-title":"PLoS Pathog"},{"issue":"4","key":"488_CR9","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1073\/pnas.252756299","volume":"100","author":"MR Arkin","year":"2003","unstructured":"Arkin MR et al (2003) Binding of small molecules to an adaptive protein-protein interface. Proc Natl Acad Sci U S A 100(4):1603\u20131608","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"488_CR10","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.chembiol.2014.09.001","volume":"21","author":"MR Arkin","year":"2014","unstructured":"Arkin MR, Tang Y, Wells JA (2014) Small-molecule inhibitors of protein-protein interactions: progressing toward the reality. Chem Biol 21(9):1102\u20131114","journal-title":"Chem Biol"},{"issue":"18","key":"488_CR11","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1182\/blood-2012-09-458935","volume":"121","author":"M Askmyr","year":"2013","unstructured":"Askmyr M et al (2013) Selective killing of candidate AML stem cells by antibody targeting of IL1RAP. Blood 121(18):3709\u20133713","journal-title":"Blood"},{"issue":"10","key":"488_CR12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMc1811317","volume":"380","author":"H Bachelez","year":"2019","unstructured":"Bachelez H et al (2019) Inhibition of the interleukin-36 pathway for the treatment of generalized pustular psoriasis. N Engl J Med 380(10):981\u2013983","journal-title":"N Engl J Med"},{"key":"488_CR13","doi-asserted-by":"crossref","unstructured":"Bal E et al (2017) Mutation in IL36RN impairs the processing and regulatory function of the interleukin-36-receptor antagonist and is associated with DITRA syndrome. Exp Dermatol","DOI":"10.1111\/exd.13387"},{"issue":"11","key":"488_CR14","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1002\/1521-4141(200011)30:11<3299::AID-IMMU3299>3.0.CO;2-S","volume":"30","author":"JL Barton","year":"2000","unstructured":"Barton JL et al (2000) A tissue specific IL-1 receptor antagonist homolog from the IL-1 cluster lacks IL-1, IL-1ra, IL-18 and IL-18 antagonist activities. Eur J Immunol 30(11):3299\u20133308","journal-title":"Eur J Immunol"},{"issue":"5482","key":"488_CR15","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1126\/science.289.5482.1185","volume":"289","author":"A Belaaouaj","year":"2000","unstructured":"Belaaouaj A, Kim KS, Shapiro SD (2000) Degradation of outer membrane protein a in Escherichia coli killing by neutrophil elastase. Science 289(5482):1185\u20131188","journal-title":"Science"},{"issue":"11","key":"488_CR16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1089\/107999001753289505","volume":"21","author":"JT Bensen","year":"2001","unstructured":"Bensen JT et al (2001) Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12\u201314. J Interf Cytokine Res 21(11):899\u2013904","journal-title":"J Interf Cytokine Res"},{"issue":"1\u20132","key":"488_CR17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0165-5728(03)00130-9","volume":"139","author":"E Berglof","year":"2003","unstructured":"Berglof E et al (2003) IL-1Rrp2 expression and IL-1F9 (IL-1H1) actions in brain cells. J Neuroimmunol 139(1\u20132):36\u201343","journal-title":"J Neuroimmunol"},{"issue":"11","key":"488_CR18","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1084\/jem.20070157","volume":"204","author":"H Blumberg","year":"2007","unstructured":"Blumberg H et al (2007) Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med 204(11):2603\u20132614","journal-title":"J Exp Med"},{"issue":"7","key":"488_CR19","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.4049\/jimmunol.1000313","volume":"185","author":"H Blumberg","year":"2010","unstructured":"Blumberg H et al (2010) IL-1RL2 and its ligands contribute to the cytokine network in psoriasis. J Immunol 185(7):4354\u20134362","journal-title":"J Immunol"},{"issue":"2","key":"488_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cei.12761","volume":"184","author":"MA Boutet","year":"2016","unstructured":"Boutet MA et al (2016) Distinct expression of interleukin (IL)-36alpha, beta and gamma, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn\u2019s disease. Clin Exp Immunol 184(2):159\u2013173","journal-title":"Clin Exp Immunol"},{"key":"488_CR21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12974-015-0392-7","volume":"12","author":"L Bozoyan","year":"2015","unstructured":"Bozoyan L et al (2015) Interleukin-36gamma is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis. J Neuroinflammation 12:173","journal-title":"J Neuroinflammation"},{"issue":"6","key":"488_CR22","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.jaci.2018.02.040","volume":"141","author":"PM Brunner","year":"2018","unstructured":"Brunner PM et al (2018) Early-onset pediatric atopic dermatitis is characterized by TH2\/TH17\/TH22-centered inflammation and lipid alterations. J Allergy Clin Immunol 141(6):2094\u20132106","journal-title":"J Allergy Clin Immunol"},{"key":"488_CR23","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3389\/fimmu.2019.01162","volume":"10","author":"AL Buhl","year":"2019","unstructured":"Buhl AL, Wenzel J (2019) Interleukin-36 in infectious and inflammatory skin diseases. Front Immunol 10:1162","journal-title":"Front Immunol"},{"issue":"2","key":"488_CR24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/geno.2000.6184","volume":"66","author":"SJ Busfield","year":"2000","unstructured":"Busfield SJ et al (2000) Identification and gene organization of three novel members of the IL-1 family on human chromosome 2. Genomics 66(2):213\u2013216","journal-title":"Genomics"},{"issue":"12","key":"488_CR25","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1038\/jid.2011.234","volume":"131","author":"Y Carrier","year":"2011","unstructured":"Carrier Y et al (2011) Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis. J Invest Dermatol 131(12):2428\u20132437","journal-title":"J Invest Dermatol"},{"key":"488_CR26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12879-016-1555-6","volume":"16","author":"Z Chen","year":"2016","unstructured":"Chen Z et al (2016) Increased concentrations of soluble B7-H3 and interleukin 36 in bronchoalveolar lavage fluid of children with mycoplasma pneumoniae pneumonia. BMC Infect Dis 16:212","journal-title":"BMC Infect Dis"},{"issue":"11","key":"488_CR27","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/febs.14075","volume":"284","author":"DM Clancy","year":"2017","unstructured":"Clancy DM et al (2017) Neutrophil extracellular traps can serve as platforms for processing and activation of IL-1 family cytokines. FEBS J 284(11):1712\u20131725","journal-title":"FEBS J"},{"issue":"11","key":"488_CR28","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.celrep.2018.02.062","volume":"22","author":"DM Clancy","year":"2018","unstructured":"Clancy DM et al (2018) Extracellular neutrophil proteases are efficient regulators of IL-1, IL-33, and IL-36 cytokine activity but poor effectors of microbial killing. Cell Rep 22(11):2937\u20132950","journal-title":"Cell Rep"},{"issue":"1","key":"488_CR29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/geno.1999.5767","volume":"57","author":"M Dale","year":"1999","unstructured":"Dale M, Nicklin MJ (1999) Interleukin-1 receptor cluster: gene organization of IL1R2, IL1R1, IL1RL2 (IL-1Rrp2), IL1RL1 (T1\/ST2), and IL18R1 (IL-1Rrp) on human chromosome 2q. Genomics 57(1):177\u2013179","journal-title":"Genomics"},{"issue":"3","key":"488_CR30","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.4049\/jimmunol.167.3.1440","volume":"167","author":"R Debets","year":"2001","unstructured":"Debets R et al (2001) Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J Immunol 167(3):1440\u20131446","journal-title":"J Immunol"},{"issue":"8","key":"488_CR31","doi-asserted-by":"crossref","first-page":"e101954","DOI":"10.1371\/journal.pone.0101954","volume":"9","author":"A Derer","year":"2014","unstructured":"Derer A et al (2014) Blockade of IL-36 receptor signaling does not prevent from TNF-induced arthritis. PLoS One 9(8):e101954","journal-title":"PLoS One"},{"issue":"11","key":"488_CR32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrrheum.2014.156","volume":"10","author":"D Dietrich","year":"2014","unstructured":"Dietrich D, Gabay C (2014) Inflammation: IL-36 has proinflammatory effects in skin but not in joints. Nat Rev Rheumatol 10(11):639\u2013640","journal-title":"Nat Rev Rheumatol"},{"issue":"37","key":"488_CR33","doi-asserted-by":"crossref","first-page":"10938","DOI":"10.1021\/bi0341197","volume":"42","author":"EF Dunn","year":"2003","unstructured":"Dunn EF et al (2003) High-resolution structure of murine interleukin 1 homologue IL-1F5 reveals unique loop conformations for receptor binding specificity. Biochemistry 42(37):10938\u201310944","journal-title":"Biochemistry"},{"issue":"171","key":"488_CR34","doi-asserted-by":"crossref","first-page":"re3","DOI":"10.1126\/stke.2003.171.re3","volume":"2003","author":"A Dunne","year":"2003","unstructured":"Dunne A, O'Neill LA (2003) The interleukin-1 receptor\/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2003(171):re3","journal-title":"Sci STKE"},{"issue":"1","key":"488_CR35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/humu.22203","volume":"34","author":"M Farooq","year":"2013","unstructured":"Farooq M et al (2013) Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis. Hum Mutat 34(1):176\u2013183","journal-title":"Hum Mutat"},{"key":"488_CR36","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3389\/fimmu.2019.01412","volume":"10","author":"JK Fields","year":"2019","unstructured":"Fields JK, Gunther S, Sundberg EJ (2019) Structural basis of IL-1 family cytokine Signaling. Front Immunol 10:1412","journal-title":"Front Immunol"},{"key":"488_CR37","doi-asserted-by":"crossref","first-page":"5140691","DOI":"10.1155\/2018\/5140691","volume":"2018","author":"G Fonseca-Camarillo","year":"2018","unstructured":"Fonseca-Camarillo G et al (2018) Differential expression of IL-36 family members and IL-38 by immune and nonimmune cells in patients with active inflammatory bowel disease. Biomed Res Int 2018:5140691","journal-title":"Biomed Res Int"},{"issue":"9","key":"488_CR38","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1136\/annrheumdis-2012-202264","volume":"72","author":"S Frey","year":"2013","unstructured":"Frey S et al (2013) The novel cytokine interleukin-36alpha is expressed in psoriatic and rheumatoid arthritis synovium. Ann Rheum Dis 72(9):1569\u20131574","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"488_CR39","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1189\/jlb.3RI1014-495R","volume":"97","author":"C Gabay","year":"2015","unstructured":"Gabay C, Towne JE (2015) Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions. J Leukoc Biol 97(4):645\u2013652","journal-title":"J Leukoc Biol"},{"issue":"7","key":"488_CR40","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1080\/19420862.2017.1353853","volume":"9","author":"R Ganesan","year":"2017","unstructured":"Ganesan R et al (2017) Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies. MAbs 9(7):1143\u20131154","journal-title":"MAbs"},{"key":"488_CR41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cyto.2018.07.034","volume":"111","author":"JK Gardner","year":"2018","unstructured":"Gardner JK, Herbst-Kralovetz MM (2018) IL-36gamma induces a transient HSV-2 resistant environment that protects against genital disease and pathogenesis. Cytokine 111:63\u201371","journal-title":"Cytokine"},{"issue":"6625","key":"488_CR42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/386619a0","volume":"386","author":"T Ghayur","year":"1997","unstructured":"Ghayur T et al (1997) Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386(6625):619\u2013623","journal-title":"Nature"},{"issue":"2","key":"488_CR43","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/eji.201242711","volume":"43","author":"MS Gresnigt","year":"2013","unstructured":"Gresnigt MS et al (2013) The IL-36 receptor pathway regulates Aspergillus fumigatus-induced Th1 and Th17 responses. Eur J Immunol 43(2):416\u2013426","journal-title":"Eur J Immunol"},{"issue":"2","key":"488_CR44","doi-asserted-by":"crossref","first-page":"921","DOI":"10.4049\/jimmunol.1400538","volume":"193","author":"S Gunther","year":"2014","unstructured":"Gunther S, Sundberg EJ (2014) Molecular determinants of agonist and antagonist signaling through the IL-36 receptor. J Immunol 193(2):921\u2013930","journal-title":"J Immunol"},{"issue":"3","key":"488_CR45","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.immuni.2017.08.004","volume":"47","author":"S Gunther","year":"2017","unstructured":"Gunther S et al (2017) IL-1 family cytokines use distinct molecular mechanisms to signal through their shared co-receptor. Immunity 47(3):510\u2013523.e4","journal-title":"Immunity"},{"key":"488_CR46","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2147\/DDDT.S194765","volume":"13","author":"J Guo","year":"2019","unstructured":"Guo J et al (2019) Cathepsin G cleaves and activates IL-36gamma and promotes the inflammation of psoriasis. Drug Des Devel Ther 13:581\u2013588","journal-title":"Drug Des Devel Ther"},{"issue":"6","key":"488_CR47","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/mi.2017.21","volume":"10","author":"A Harusato","year":"2017","unstructured":"Harusato A et al (2017) IL-36gamma signaling controls the induced regulatory T cell-Th9 cell balance via NFkappaB activation and STAT transcription factors. Mucosal Immunol 10(6):1455\u20131467","journal-title":"Mucosal Immunol"},{"issue":"12","key":"488_CR48","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/cr.2015.139","volume":"25","author":"WT He","year":"2015","unstructured":"He WT et al (2015) Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion. Cell Res 25(12):1285\u20131298","journal-title":"Cell Res"},{"issue":"4","key":"488_CR49","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.celrep.2015.12.072","volume":"14","author":"CM Henry","year":"2016","unstructured":"Henry CM et al (2016) Neutrophil-derived proteases escalate inflammation through activation of IL-36 family cytokines. Cell Rep 14(4):708\u2013722","journal-title":"Cell Rep"},{"key":"488_CR50","doi-asserted-by":"crossref","unstructured":"H\u00f8jen JF et al (2019) IL-1R3 blockade broadly attenuates the functions of six members of the IL-1 family, revealing their contribution to models of disease. Nat Immunol","DOI":"10.1038\/s41590-019-0467-1"},{"key":"488_CR51","unstructured":"Irina Khanskaya, J.P., Margaret H Marino, Traci Savall, Jie Li, Marco Londei (2018) A phase 1 study of ANB019, an anti-IL-36 receptor monoclonal antibody, in healthy volunteers. Available from https:\/\/www2.anaptysbio.com\/wp-content\/uploads\/ANB019-Phase-1-Study-Poster-EAACI-2018.pdf"},{"issue":"37","key":"488_CR52","doi-asserted-by":"crossref","first-page":"16280","DOI":"10.1073\/pnas.1004408107","volume":"107","author":"M Jaras","year":"2010","unstructured":"Jaras M et al (2010) Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein. Proc Natl Acad Sci U S A 107(37):16280\u201316285","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"488_CR53","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.4049\/jimmunol.1003162","volume":"186","author":"A Johnston","year":"2011","unstructured":"Johnston A et al (2011) IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression. J Immunol 186(4):2613\u20132622","journal-title":"J Immunol"},{"key":"488_CR54","first-page":"69","volume":"2","author":"T Kanda","year":"2015","unstructured":"Kanda T et al (2015) Interleukin(IL)-36alpha and IL-36gamma induce proinflammatory mediators from human colonic subepithelial myofibroblasts. Front Med (Lausanne) 2:69","journal-title":"Front Med (Lausanne)"},{"issue":"7575","key":"488_CR55","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki N et al (2015) Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526(7575):666\u2013671","journal-title":"Nature"},{"key":"488_CR56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-2094-11-27","volume":"11","author":"B Klementiev","year":"2014","unstructured":"Klementiev B et al (2014) Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist. J Neuroinflammation 11:27","journal-title":"J Neuroinflammation"},{"issue":"2","key":"488_CR57","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1189\/jlb.4A0315-087R","volume":"100","author":"MA Kovach","year":"2016","unstructured":"Kovach MA et al (2016) IL-36gamma is secreted in microparticles and exosomes by lung macrophages in response to bacteria and bacterial components. J Leukoc Biol 100(2):413\u2013421","journal-title":"J Leukoc Biol"},{"issue":"5","key":"488_CR58","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/mi.2016.130","volume":"10","author":"MA Kovach","year":"2017","unstructured":"Kovach MA et al (2017) IL-36gamma is a crucial proximal component of protective type-1-mediated lung mucosal immunity in gram-positive and -negative bacterial pneumonia. Mucosal Immunol 10(5):1320\u20131334","journal-title":"Mucosal Immunol"},{"issue":"14","key":"488_CR59","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1074\/jbc.275.14.10308","volume":"275","author":"S Kumar","year":"2000","unstructured":"Kumar S et al (2000) Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem 275(14):10308\u201310314","journal-title":"J Biol Chem"},{"issue":"2","key":"488_CR60","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/ar4192","volume":"15","author":"C Lamacchia","year":"2013","unstructured":"Lamacchia C et al (2013) The severity of experimental arthritis is independent of IL-36 receptor signaling. Arthritis Res Ther 15(2):R38","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"488_CR61","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.4049\/jimmunol.1302574","volume":"193","author":"N Li","year":"2014","unstructured":"Li N et al (2014) Alarmin function of cathelicidin antimicrobial peptide LL37 through IL-36gamma induction in human epidermal keratinocytes. J Immunol 193(10):5140\u20135148","journal-title":"J Immunol"},{"key":"488_CR62","doi-asserted-by":"crossref","unstructured":"Li T et al (2019) TGF-beta type 2 receptor-mediated modulation of the IL-36 family can be therapeutically targeted in osteoarthritis. Sci Transl Med 11(491)","DOI":"10.1126\/scitranslmed.aan2585"},{"issue":"5","key":"488_CR63","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/jid.2011.482","volume":"132","author":"LH Lian","year":"2012","unstructured":"Lian LH et al (2012) The double-stranded RNA analogue polyinosinic-polycytidylic acid induces keratinocyte pyroptosis and release of IL-36gamma. J Invest Dermatol 132(5):1346\u20131353","journal-title":"J Invest Dermatol"},{"issue":"23","key":"488_CR64","doi-asserted-by":"crossref","first-page":"20597","DOI":"10.1074\/jbc.M010095200","volume":"276","author":"H Lin","year":"2001","unstructured":"Lin H et al (2001) Cloning and characterization of IL-1HY2, a novel interleukin-1 family member. J Biol Chem 276(23):20597\u201320602","journal-title":"J Biol Chem"},{"issue":"37","key":"488_CR65","doi-asserted-by":"crossref","first-page":"14918","DOI":"10.1073\/pnas.1308651110","volume":"110","author":"X Liu","year":"2013","unstructured":"Liu X et al (2013) Structural insights into the interaction of IL-33 with its receptors. Proc Natl Acad Sci U S A 110(37):14918\u201314923","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"488_CR66","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.chom.2017.10.006","volume":"22","author":"H Liu","year":"2017","unstructured":"Liu H et al (2017) Staphylococcus aureus Epicutaneous exposure drives skin inflammation via IL-36-mediated T cell responses. Cell Host Microbe 22(5):653\u2013666. e5","journal-title":"Cell Host Microbe"},{"issue":"2","key":"488_CR67","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-5728(96)00047-1","volume":"70","author":"TW Lovenberg","year":"1996","unstructured":"Lovenberg TW et al (1996) Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL 1R-rp2). J Neuroimmunol 70(2):113\u2013122","journal-title":"J Neuroimmunol"},{"key":"488_CR68","doi-asserted-by":"crossref","first-page":"24880","DOI":"10.1038\/srep24880","volume":"6","author":"T Macleod","year":"2016","unstructured":"Macleod T et al (2016) Neutrophil elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 receptor antagonist. Sci Rep 6:24880","journal-title":"Sci Rep"},{"issue":"3","key":"488_CR69","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/ar1946","volume":"8","author":"D Magne","year":"2006","unstructured":"Magne D et al (2006) The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes. Arthritis Res Ther 8(3):R80","journal-title":"Arthritis Res Ther"},{"key":"488_CR70","doi-asserted-by":"crossref","unstructured":"Mahil SK et al (2017) An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target. Sci Transl Med 9(411)","DOI":"10.1126\/scitranslmed.aan2514"},{"issue":"2","key":"488_CR71","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaci.2018.03.021","volume":"143","author":"K Malik","year":"2019","unstructured":"Malik K et al (2019) Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature. J Allergy Clin Immunol 143(2):604\u2013618","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"488_CR72","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","volume":"365","author":"S Marrakchi","year":"2011","unstructured":"Marrakchi S et al (2011) Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 365(7):620\u2013628","journal-title":"N Engl J Med"},{"issue":"6","key":"488_CR73","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.4049\/jimmunol.0803301","volume":"183","author":"U Martin","year":"2009","unstructured":"Martin U et al (2009) Externalization of the leaderless cytokine IL-1F6 occurs in response to lipopolysaccharide\/ATP activation of transduced bone marrow macrophages. J Immunol 183(6):4021\u20134030","journal-title":"J Immunol"},{"issue":"2","key":"488_CR74","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10(2):417\u2013426","journal-title":"Mol Cell"},{"issue":"12","key":"488_CR75","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/exd.12272","volume":"22","author":"M Mattii","year":"2013","unstructured":"Mattii M et al (2013) The balance between pro- and anti-inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: the role of IL-1 family members. Exp Dermatol 22(12):813\u2013819","journal-title":"Exp Dermatol"},{"issue":"1","key":"488_CR76","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4049\/jimmunol.1501312","volume":"196","author":"O Medina-Contreras","year":"2016","unstructured":"Medina-Contreras O et al (2016) Cutting edge: IL-36 receptor promotes resolution of intestinal damage. J Immunol 196(1):34\u201338","journal-title":"J Immunol"},{"issue":"2","key":"488_CR77","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1097-2765(00)80136-7","volume":"2","author":"R Medzhitov","year":"1998","unstructured":"Medzhitov R et al (1998) MyD88 is an adaptor protein in the hToll\/IL-1 receptor family signaling pathways. Mol Cell 2(2):253\u2013258","journal-title":"Mol Cell"},{"issue":"11","key":"488_CR78","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41419-018-1143-3","volume":"9","author":"L Mercurio","year":"2018","unstructured":"Mercurio L et al (2018) IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment. Cell Death Dis 9(11):1104","journal-title":"Cell Death Dis"},{"issue":"1","key":"488_CR79","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2005.11.011","volume":"24","author":"LS Miller","year":"2006","unstructured":"Miller LS et al (2006) MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 24(1):79\u201391","journal-title":"Immunity"},{"issue":"1","key":"488_CR80","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1038\/s41598-017-05363-4","volume":"7","author":"KA Milora","year":"2017","unstructured":"Milora KA et al (2017) Interleukin-36beta provides protection against HSV-1 infection, but does not modulate initiation of adaptive immune responses. Sci Rep 7(1):5799","journal-title":"Sci Rep"},{"issue":"3","key":"488_CR81","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1006\/bbrc.1999.1440","volume":"263","author":"JJ Mulero","year":"1999","unstructured":"Mulero JJ et al (1999) IL1HY1: a novel interleukin-1 receptor antagonist gene. Biochem Biophys Res Commun 263(3):702\u2013706","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"488_CR82","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/eji.201142035","volume":"42","author":"S Mutamba","year":"2012","unstructured":"Mutamba S et al (2012) Expression of IL-1Rrp2 by human myelomonocytic cells is unique to DCs and facilitates DC maturation by IL-1F8 and IL-1F9. Eur J Immunol 42(3):607\u2013617","journal-title":"Eur J Immunol"},{"issue":"5","key":"488_CR83","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.chom.2017.10.008","volume":"22","author":"S Nakagawa","year":"2017","unstructured":"Nakagawa S et al (2017) Staphylococcus aureus virulent PSMalpha peptides induce keratinocyte Alarmin release to orchestrate IL-17-dependent skin inflammation. Cell Host Microbe 22(5):667\u2013677. e5","journal-title":"Cell Host Microbe"},{"key":"488_CR84","doi-asserted-by":"crossref","unstructured":"Nanjo Y et al (2019) Overlapping roles for interleukin-36 cytokines in protective host defense against murine Legionella pneumophila pneumonia. Infect Immun 87(1)","DOI":"10.1128\/IAI.00583-18"},{"issue":"22","key":"488_CR85","doi-asserted-by":"crossref","first-page":"E5076","DOI":"10.1073\/pnas.1718902115","volume":"115","author":"VL Ngo","year":"2018","unstructured":"Ngo VL et al (2018) A cytokine network involving IL-36gamma, IL-23, and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage. Proc Natl Acad Sci U S A 115(22):E5076\u2013E5085","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"488_CR86","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1006\/geno.2002.6751","volume":"79","author":"MJ Nicklin","year":"2002","unstructured":"Nicklin MJ et al (2002) A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics 79(5):718\u2013725","journal-title":"Genomics"},{"issue":"2","key":"488_CR87","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MIB.0000000000000654","volume":"22","author":"A Nishida","year":"2016","unstructured":"Nishida A et al (2016) Increased expression of Interleukin-36, a member of the interleukin-1 cytokine family, in inflammatory bowel disease. Inflamm Bowel Dis 22(2):303\u2013314","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"488_CR88","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","volume":"89","author":"A Onoufriadis","year":"2011","unstructured":"Onoufriadis A et al (2011) Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet 89(3):432\u2013437","journal-title":"Am J Hum Genet"},{"issue":"33","key":"488_CR89","doi-asserted-by":"crossref","first-page":"29355","DOI":"10.1074\/jbc.R200003200","volume":"277","author":"K Ozaki","year":"2002","unstructured":"Ozaki K, Leonard WJ (2002) Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem 277(33):29355\u201329358","journal-title":"J Biol Chem"},{"issue":"26","key":"488_CR90","doi-asserted-by":"crossref","first-page":"25233","DOI":"10.1074\/jbc.M501363200","volume":"280","author":"J Qin","year":"2005","unstructured":"Qin J et al (2005) SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms. J Biol Chem 280(26):25233\u201325241","journal-title":"J Biol Chem"},{"issue":"10","key":"488_CR91","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.4049\/jimmunol.180.10.6977","volume":"180","author":"C Quiniou","year":"2008","unstructured":"Quiniou C et al (2008) Development of a novel noncompetitive antagonist of IL-1 receptor. J Immunol 180(10):6977\u20136987","journal-title":"J Immunol"},{"issue":"2","key":"488_CR92","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1165\/rcmb.2009-0315OC","volume":"44","author":"RA Ramadas","year":"2011","unstructured":"Ramadas RA et al (2011) Interleukin-1 family member 9 stimulates chemokine production and neutrophil influx in mouse lungs. Am J Respir Cell Mol Biol 44(2):134\u2013145","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"488_CR93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045784","volume":"7","author":"RA Ramadas","year":"2012","unstructured":"Ramadas RA et al (2012) IL-36alpha exerts pro-inflammatory effects in the lungs of mice. PLoS One 7(9):e45784","journal-title":"PLoS One"},{"issue":"1","key":"488_CR94","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41467-018-03362-1","volume":"9","author":"J Rivers-Auty","year":"2018","unstructured":"Rivers-Auty J et al (2018) Redefining the ancestral origins of the interleukin-1 superfamily. Nat Commun 9(1):1156","journal-title":"Nat Commun"},{"issue":"5","key":"488_CR95","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/mi.2015.134","volume":"9","author":"SE Russell","year":"2016","unstructured":"Russell SE et al (2016) IL-36alpha expression is elevated in ulcerative colitis and promotes colonic inflammation. Mucosal Immunol 9(5):1193\u20131204","journal-title":"Mucosal Immunol"},{"issue":"39","key":"488_CR96","doi-asserted-by":"crossref","first-page":"23997","DOI":"10.1074\/jbc.M115.653378","volume":"290","author":"SS Saha","year":"2015","unstructured":"Saha SS et al (2015) Signal transduction and intracellular trafficking by the interleukin 36 receptor. J Biol Chem 290(39):23997\u201324006","journal-title":"J Biol Chem"},{"issue":"5","key":"488_CR97","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/gutjnl-2015-310374","volume":"66","author":"K Scheibe","year":"2017","unstructured":"Scheibe K et al (2017) IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo. Gut 66(5):823\u2013838","journal-title":"Gut"},{"issue":"4","key":"488_CR98","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1053\/j.gastro.2018.11.029","volume":"156","author":"K Scheibe","year":"2019","unstructured":"Scheibe K et al (2019) Inhibiting interleukin 36 receptor signaling reduces fibrosis in mice with chronic intestinal inflammation. Gastroenterology 156(4):1082\u20131097. e11","journal-title":"Gastroenterology"},{"issue":"5","key":"488_CR99","doi-asserted-by":"crossref","first-page":"e0126058","DOI":"10.1371\/journal.pone.0126058","volume":"10","author":"N Segueni","year":"2015","unstructured":"Segueni N et al (2015) Limited contribution of IL-36 versus IL-1 and TNF pathways in host response to mycobacterial infection. PLoS One 10(5):e0126058","journal-title":"PLoS One"},{"issue":"2","key":"488_CR100","first-page":"179","volume":"17","author":"M Sehat","year":"2018","unstructured":"Sehat M et al (2018) Evaluating serum levels of IL-33, IL-36, IL-37 and gene expression of IL-37 in patients with psoriasis vulgaris. Iran J Allergy Asthma Immunol 17(2):179\u2013187","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"7575","key":"488_CR101","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J et al (2015) Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526(7575):660\u2013665","journal-title":"Nature"},{"key":"488_CR102","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/msb.2011.75","volume":"7","author":"F Sievers","year":"2011","unstructured":"Sievers F et al (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal omega. Mol Syst Biol 7:539. https:\/\/doi.org\/10.1038\/msb.2011.75","journal-title":"Mol Syst Biol"},{"issue":"2","key":"488_CR103","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1074\/jbc.275.2.1169","volume":"275","author":"DE Smith","year":"2000","unstructured":"Smith DE et al (2000) Four new members expand the interleukin-1 superfamily. J Biol Chem 275(2):1169\u20131175","journal-title":"J Biol Chem"},{"key":"488_CR104","doi-asserted-by":"crossref","unstructured":"Song Y et al (2019) Interleukin-36 alpha levels are elevated in the serum and cerebrospinal fluid of patients with neuromyelitis optica spectrum disorder and correlate with disease activity. Immunobiology","DOI":"10.1016\/j.imbio.2019.02.008"},{"key":"488_CR105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-immunol-032713-120211","volume":"33","author":"JB Spangler","year":"2015","unstructured":"Spangler JB et al (2015) Insights into cytokine-receptor interactions from cytokine engineering. Annu Rev Immunol 33:139\u2013167","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"488_CR106","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/exd.13841","volume":"28","author":"Z Su","year":"2019","unstructured":"Su Z et al (2019) IL-36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis. Exp Dermatol 28(2):113\u2013120","journal-title":"Exp Dermatol"},{"issue":"5","key":"488_CR107","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/2211-5463.12406","volume":"8","author":"GP Sullivan","year":"2018","unstructured":"Sullivan GP et al (2018) Identification of small-molecule elastase inhibitors as antagonists of IL-36 cytokine activation. FEBS Open Bio 8(5):751\u2013763","journal-title":"FEBS Open Bio"},{"key":"488_CR108","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cbpa.2014.08.013","volume":"23","author":"TB Sundberg","year":"2014","unstructured":"Sundberg TB et al (2014) Small-molecule control of cytokine function: new opportunities for treating immune disorders. Curr Opin Chem Biol 23:23\u201330","journal-title":"Curr Opin Chem Biol"},{"key":"488_CR109","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fimmu.2018.00080","volume":"9","author":"WR Swindell","year":"2018","unstructured":"Swindell WR et al (2018) RNA-Seq analysis of IL-1B and IL-36 responses in epidermal keratinocytes identifies a shared MyD88-dependent gene signature. Front Immunol 9:80","journal-title":"Front Immunol"},{"issue":"5","key":"488_CR110","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1006\/geno.2002.6752","volume":"79","author":"SL Taylor","year":"2002","unstructured":"Taylor SL et al (2002) Genomic organization of the interleukin-1 locus. Genomics 79(5):726\u2013733","journal-title":"Genomics"},{"issue":"4","key":"488_CR111","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nsmb.2260","volume":"19","author":"C Thomas","year":"2012","unstructured":"Thomas C, Bazan JF, Garcia KC (2012) Structure of the activating IL-1 receptor signaling complex. Nat Struct Mol Biol 19(4):455\u2013457","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"488_CR112","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.4049\/jimmunol.1002526","volume":"187","author":"RL Tiwari","year":"2011","unstructured":"Tiwari RL et al (2011) IL-1R-associated kinase-1 mediates protein kinase Cdelta-induced IL-1beta production in monocytes. J Immunol 187(5):2632\u20132645","journal-title":"J Immunol"},{"issue":"1","key":"488_CR113","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1038\/s41598-019-45626-w","volume":"9","author":"V Todorovic","year":"2019","unstructured":"Todorovic V et al (2019) Small molecule IL-36gamma antagonist as a novel therapeutic approach for plaque psoriasis. Sci Rep 9(1):9089","journal-title":"Sci Rep"},{"issue":"2","key":"488_CR114","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00383-016-4011-1","volume":"33","author":"C Tomuschat","year":"2017","unstructured":"Tomuschat C et al (2017) Altered expression of IL36gamma and IL36 receptor (IL1RL2) in the colon of patients with Hirschsprung's disease. Pediatr Surg Int 33(2):181\u2013186","journal-title":"Pediatr Surg Int"},{"issue":"11","key":"488_CR115","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1172\/JCI63451","volume":"122","author":"L Tortola","year":"2012","unstructured":"Tortola L et al (2012) Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J Clin Invest 122(11):3965\u20133976","journal-title":"J Clin Invest"},{"issue":"14","key":"488_CR116","doi-asserted-by":"crossref","first-page":"13677","DOI":"10.1074\/jbc.M400117200","volume":"279","author":"JE Towne","year":"2004","unstructured":"Towne JE et al (2004) Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J Biol Chem 279(14):13677\u201313688","journal-title":"J Biol Chem"},{"issue":"49","key":"488_CR117","doi-asserted-by":"crossref","first-page":"42594","DOI":"10.1074\/jbc.M111.267922","volume":"286","author":"JE Towne","year":"2011","unstructured":"Towne JE et al (2011) Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36alpha, IL-36beta, and IL-36gamma) or antagonist (IL-36Ra) activity. J Biol Chem 286(49):42594\u201342602","journal-title":"J Biol Chem"},{"key":"488_CR118","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1038\/ncomms6340","volume":"5","author":"N Tsutsumi","year":"2014","unstructured":"Tsutsumi N et al (2014) The structural basis for receptor recognition of human interleukin-18. Nat Commun 5:5340","journal-title":"Nat Commun"},{"issue":"8","key":"488_CR119","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1073\/pnas.1121534109","volume":"109","author":"FL van de Veerdonk","year":"2012","unstructured":"van de Veerdonk FL et al (2012) IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc Natl Acad Sci U S A 109(8):3001\u20133005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"488_CR120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/imr.12612","volume":"281","author":"FL van de Veerdonk","year":"2018","unstructured":"van de Veerdonk FL et al (2018) Biology of IL-38 and its role in disease. Immunol Rev 281(1):191\u2013196","journal-title":"Immunol Rev"},{"issue":"22","key":"488_CR121","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1182\/blood-2011-05-356873","volume":"118","author":"S Vigne","year":"2011","unstructured":"Vigne S et al (2011) IL-36R ligands are potent regulators of dendritic and T cells. Blood 118(22):5813\u20135823","journal-title":"Blood"},{"issue":"6","key":"488_CR122","first-page":"245","volume":"29","author":"P Wang","year":"2005","unstructured":"Wang P et al (2005) The interleukin-1-related cytokine IL-1F8 is expressed in glial cells, but fails to induce IL-1beta signalling responses. Cytokine 29(6):245\u2013250","journal-title":"Cytokine"},{"issue":"10","key":"488_CR123","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ni.1925","volume":"11","author":"D Wang","year":"2010","unstructured":"Wang D et al (2010) Structural insights into the assembly and activation of IL-1beta with its receptors. Nat Immunol 11(10):905\u2013911","journal-title":"Nat Immunol"},{"issue":"6884","key":"488_CR124","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/417091a","volume":"417","author":"Y Weinrauch","year":"2002","unstructured":"Weinrauch Y et al (2002) Neutrophil elastase targets virulence factors of enterobacteria. Nature 417(6884):91\u201394","journal-title":"Nature"},{"issue":"9","key":"488_CR125","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.4155\/fmc.15.56","volume":"7","author":"A Whitty","year":"2015","unstructured":"Whitty A, Zhou L (2015) Horses for courses: reaching outside drug-like chemical space for inhibitors of challenging drug targets. Future Med Chem 7(9):1093\u20131095","journal-title":"Future Med Chem"},{"issue":"2","key":"488_CR126","doi-asserted-by":"crossref","first-page":"e0118671","DOI":"10.1371\/journal.pone.0118671","volume":"10","author":"CY Yang","year":"2015","unstructured":"Yang CY (2015) Identification of potential small molecule allosteric modulator sites on IL-1R1 ectodomain using accelerated conformational sampling method. PLoS One 10(2):e0118671","journal-title":"PLoS One"},{"issue":"32","key":"488_CR127","doi-asserted-by":"crossref","first-page":"16597","DOI":"10.1074\/jbc.M116.723064","volume":"291","author":"G Yi","year":"2016","unstructured":"Yi G et al (2016) Structural and functional attributes of the Interleukin-36 receptor. J Biol Chem 291(32):16597\u201316609","journal-title":"J Biol Chem"},{"issue":"7","key":"488_CR128","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.4049\/jimmunol.160.7.3170","volume":"160","author":"DY Yoon","year":"1998","unstructured":"Yoon DY, Dinarello CA (1998) Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1 beta activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein. J Immunol 160(7):3170\u20133179","journal-title":"J Immunol"},{"key":"488_CR129","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cyto.2017.08.022","volume":"99","author":"J Zhang","year":"2017","unstructured":"Zhang J et al (2017) IL-36 induces cytokine IL-6 and chemokine CXCL8 expression in human lung tissue cells: implications for pulmonary inflammatory responses. Cytokine 99:114\u2013123","journal-title":"Cytokine"},{"key":"488_CR130","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.biopha.2018.07.099","volume":"107","author":"P Zheng","year":"2018","unstructured":"Zheng P et al (2018) Synthetic human monoclonal antibody targets hIL1 receptor accessory protein chain with therapeutic potential in triple-negative breast cancer. Biomed Pharmacother 107:1064\u20131073","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"488_CR131","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1074\/jbc.M117.805739","volume":"293","author":"L Zhou","year":"2018","unstructured":"Zhou L et al (2018) Quantitative ligand and receptor binding studies reveal the mechanism of interleukin-36 (IL-36) pathway activation. J Biol Chem 293(2):403\u2013411","journal-title":"J Biol Chem"}],"container-title":["Advances in Experimental Medicine and Biology","Protein Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2020_488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T07:35:02Z","timestamp":1695713702000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/5584_2020_488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030678135","9783030678142"],"references-count":131,"URL":"https:\/\/doi.org\/10.1007\/5584_2020_488","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"6 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}